Presentation is loading. Please wait.

Presentation is loading. Please wait.

Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks  Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,

Published byHertha Walter Modified over 6 years ago

Similar presentations

Presentation on theme: "Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks  Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,"— Presentation transcript:

1 Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks  Sripal Bangalore, MD, MHA, Gbenga Ogedegbe, MD, MS, MPH, Joyce Gyamfi, MS, Yu Guo, MA, Jason Roy, PhD, Keith Goldfeld, DrPH, Christopher Torgersen, MBA, Louis Capponi, MD, Christopher Phillips, MD, MPH, Nirav R. Shah, MD, MPH  The American Journal of Medicine  Volume 128, Issue 11, Pages (November 2015) DOI: /j.amjmed Copyright © 2015 Elsevier Inc. Terms and Conditions

2 Figure 1 Angiotensin-converting enzyme inhibitor vs calcium channel blocker: risk of primary outcome. ACEi = angiotensin-converting enzyme inhibitor; CCB = calcium channel blocker. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2015 Elsevier Inc. Terms and Conditions

3 Figure 2 Angiotensin-converting enzyme inhibitor vs thiazide diuretic: risk of primary outcome. ACEi = angiotensin-converting enzyme inhibitor; CCB = calcium channel blocker. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2015 Elsevier Inc. Terms and Conditions

4 Figure 3 Angiotensin-converting enzyme inhibitor vs β-blockers: risk of primary outcome. ACEi = angiotensin-converting enzyme inhibitor; CCB = calcium channel blocker. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2015 Elsevier Inc. Terms and Conditions

Download ppt "Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks  Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,"

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Arif H. Kamal, MD, MBA, MHS, Janet H. Bull, MD, MBA, Keith M

Arif H. Kamal, MD, MBA, MHS, Janet H. Bull, MD, MBA, Keith M
Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema  Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema  Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Bora Toklu,

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Bora Toklu,
Amay Parikh, MD, MBA, MS, Kunal Gupta, MD, MBA, Alan C

Amay Parikh, MD, MBA, MS, Kunal Gupta, MD, MBA, Alan C
Salt, Tomato Soup, and the Hypocrisy of the American Heart Association

Salt, Tomato Soup, and the Hypocrisy of the American Heart Association
Isolated Systolic Hypertension: An Update After SPRINT

Isolated Systolic Hypertension: An Update After SPRINT
Sexuality The American Journal of Medicine

Sexuality The American Journal of Medicine
What Started This? Debilitating Longitudinally-extensive Myelitis

What Started This? Debilitating Longitudinally-extensive Myelitis
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?  Sripal Bangalore, MD,

2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?  Sripal Bangalore, MD,
An Unusual Cause of Leg Ulcerations

An Unusual Cause of Leg Ulcerations
Electronic Health Record Use, Intensity of Hospital Care, and Patient Outcomes  Saul Blecker, MD, MHS, Keith Goldfeld, DrPH, Naeun Park, MS, Daniel Shine,

Electronic Health Record Use, Intensity of Hospital Care, and Patient Outcomes  Saul Blecker, MD, MHS, Keith Goldfeld, DrPH, Naeun Park, MS, Daniel Shine,
Arif H. Kamal, MD, MBA, MHS, Janet H. Bull, MD, MBA, Keith M

Arif H. Kamal, MD, MBA, MHS, Janet H. Bull, MD, MBA, Keith M
Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M
Comparative Effectiveness Research and Medical Informatics

Comparative Effectiveness Research and Medical Informatics
Integrating Physical Activity in Primary Care Practice

Integrating Physical Activity in Primary Care Practice
The Great “Infiltrator”: An Uncommon Cause of Hepatitis

The Great “Infiltrator”: An Uncommon Cause of Hepatitis
A Clinical Study of COPD Severity Assessment by Primary Care Physicians and Their Patients Compared with Spirometry  Douglas W. Mapel, MD, MPH, Anand.

A Clinical Study of COPD Severity Assessment by Primary Care Physicians and Their Patients Compared with Spirometry  Douglas W. Mapel, MD, MPH, Anand.
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc 

Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc 

Similar presentations

Ads by Google